In our previous work, we showed that AD-risk allele TREM2-R47H drives aberrant AKT signaling in microglia in tauopathy mice, and that pharmacological inhibition of AKT prevented tau-induced microglia subcluster and rescued synapse loss [35]. The gene discussed is TREM2; the disease is Alzheimer disease.